Advertisement

Pediatric Intraocular Retinoblastoma: Treatment

  • Parag K. Shah
  • Saurabh Aurora
  • V. Narendran
  • N. Kalpana
Chapter
Part of the Pediatric Cancer book series (PECA, volume 3)

Abstract

The management of retinoblastoma has evolved remarkably for the past century, and lately there is a drift towards focal conservative treatments. The challenge remains, however, in maintaining the eye and vision. Tumor reduction by diverse first-line chemotherapy protocols followed by local treatments like cryotherapy, laser photocoagulation, thermotherapy, and plaque radiotherapy is now accepted as treatment strategy for intraocular retinoblastoma with the goal of avoiding external beam radiotherapy (EBRT) or enucleation. However in most eyes with large tumors with diffuse vitreous and subretinal seeds, the EBRT or enucleation is eventually required. Chemoprophylaxis is necessary for preventing metastases in tumors with high-risk pathology features (tumor extending beyond lamina cribrosa of the optic nerve, tumor extending till the surgical margin of the optic nerve, massive choroidal invasion, scleral involvement or anterior segment involvement). Intensified chemotherapy with autologous stem cell rescue appears effective for patients with metastatic retinoblastoma. Recently, ophthalmic intra-arterial infusion with melphalan is proved as an excellent globe conserving treatment option in advanced retinoblastoma cases with minimal systemic side effects. Progress in the clinical recognition and management of retinoblastoma has led to high survival rates.

Keywords

Retinal Detachment Ophthalmic Artery Neovascular Glaucoma Orbital Cellulitis Freeze Orbit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abramson DH, Frank CM (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthal­mology 105:573–579PubMedCrossRefGoogle Scholar
  2. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP (2008) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115:1398–1404PubMedCrossRefGoogle Scholar
  3. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629PubMedCrossRefGoogle Scholar
  4. Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH (2009) Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 119:13–22PubMedCrossRefGoogle Scholar
  5. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodríguez-Galindo C, Schvartzman E, Popovic MB, Kremens B, Meadows AT, Zucker JM (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47:801–805PubMedCrossRefGoogle Scholar
  6. Christmas NJ, Van Quil IK, Murray TG, Gordon CD, Garonzik S, Tse D, Johnson T, Schiffman J, O’Brien JM (2000) Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 118:503–506PubMedCrossRefGoogle Scholar
  7. Mohri M (1993) The development of a new system of selective ophthalmic arterial infusion for the patients of intraocular retinoblastoma (in Japanese). Keio Igaku (J Keio Med Soc) 70:679–687Google Scholar
  8. Moscinski LC, Pendergrass TW, Weiss A, Hvizdala E, Buckley KS, Kalina RE (1996) Recommendations for the use of routine bone marrow aspiration and lumbar punctures in the follow-up of patients with retinoblastoma. J Pediatr Hematol Oncol 18:130–134PubMedCrossRefGoogle Scholar
  9. Murphree AL (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18:41–53CrossRefGoogle Scholar
  10. Reese AB, Hyman GA, Merriam GR Jr, Forrest AW, Kligerman MM (1954) Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol 53:505–513PubMedCrossRefGoogle Scholar
  11. Roarty JD, McLean IW, Zimmerman LE (1988) Incidence of second neoplasms in patients with retinoblastoma. Ophthalmology 95:1583–1587PubMedCrossRefGoogle Scholar
  12. Shields JA (1994) The expanding role of laser photocoagulation for intraocular tumors. The 1993 H. Christian Zweng Memorial Lecture. Retina 14:310–322PubMedCrossRefGoogle Scholar
  13. Shields JA, Shields CL (1999) Retinoblastoma. In: Atlas of intraocular tumors. Lippincott Williams & Wilkins, Philadelphia, pp 207–232Google Scholar
  14. Shields JA, Shields CL (2008) Retinoblastoma. In: Atlas of intraocular tumors. Lippincott Williams & Wilkins, Philadelphia, pp 293–365Google Scholar
  15. Shields JA, Parsons H, Shields CL, Giblin ME (1989) The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 108:260–264PubMedGoogle Scholar
  16. Shields CL, Shields JA, De Potter P, Singh AD (1993) Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 91:177–189PubMedCentralPubMedGoogle Scholar
  17. Shields CL, Shields JA, Kiratli H, De Potter PV (1995) Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus 32:317–322PubMedGoogle Scholar
  18. Shields CL, Santos MC, Diniz W, Gunduz K, Mercado G, Cater JR, Shields JA (1999) Thermotherapy for retinoblastoma. Arch Ophthalmol 117:885–893PubMedCrossRefGoogle Scholar
  19. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF (2001a) Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119:1269–1272PubMedCrossRefGoogle Scholar
  20. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B (2001b) Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 108:2116–2121PubMedCrossRefGoogle Scholar
  21. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280PubMedCrossRefGoogle Scholar
  22. Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA (2009) Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol 127:282–290PubMedCrossRefGoogle Scholar
  23. Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, Shields JA (2011) Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications. Arch Ophthalmol 129:1407–1415PubMedCrossRefGoogle Scholar
  24. Suzuki S, Yamane T, Mohri M, Kaneko A (2011) Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology 118:2081–2087PubMedCrossRefGoogle Scholar
  25. Tawansy KA, Samuel MA, Shammas M, Murphree AL (2006) Vitreoretinal complications of retinoblastoma treatment. Retina 26(7 Suppl):S47–S52PubMedCrossRefGoogle Scholar
  26. Yamane T, Kaneko A, Mohri M (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9:69–73PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Parag K. Shah
    • 1
  • Saurabh Aurora
    • 1
  • V. Narendran
    • 1
  • N. Kalpana
    • 1
  1. 1.Department of Pediatric Retina and Ocular OncologyAravind Eye HospitalCoimbatoreIndia

Personalised recommendations